Apollo Medical (AMEH) & Transatlantic Capital (TACI) Critical Contrast

Apollo Medical (NASDAQ:AMEH) and Transatlantic Capital (OTCMKTS:TACI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, valuation, risk, analyst recommendations and institutional ownership.


This table compares Apollo Medical and Transatlantic Capital’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Apollo Medical 2.08% 6.00% 2.06%
Transatlantic Capital N/A N/A N/A

Insider & Institutional Ownership

6.7% of Apollo Medical shares are owned by institutional investors. 20.5% of Apollo Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Apollo Medical and Transatlantic Capital, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Apollo Medical 0 0 1 0 3.00
Transatlantic Capital 0 0 0 0 N/A

Apollo Medical presently has a consensus price target of $25.00, indicating a potential upside of 30.89%. Given Apollo Medical’s higher possible upside, equities research analysts clearly believe Apollo Medical is more favorable than Transatlantic Capital.

Volatility and Risk

Apollo Medical has a beta of -1.17, suggesting that its stock price is 217% less volatile than the S&P 500. Comparatively, Transatlantic Capital has a beta of -3.99, suggesting that its stock price is 499% less volatile than the S&P 500.

Earnings and Valuation

This table compares Apollo Medical and Transatlantic Capital’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Apollo Medical $519.91 million 1.32 $10.84 million $0.29 65.86
Transatlantic Capital N/A N/A -$40,000.00 N/A N/A

Apollo Medical has higher revenue and earnings than Transatlantic Capital.


Apollo Medical beats Transatlantic Capital on 10 of the 10 factors compared between the two stocks.

About Apollo Medical

Apollo Medical Holdings, Inc., an integrated health care delivery and management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network consists of primary care physicians, specialist physicians, and hospitalists. The company serves the patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organizations; and non-insured patients in California. Apollo Medical Holdings, Inc. is based in Alhambra, California.

About Transatlantic Capital

Transatlantic Capital Inc. does not have significant operations. It intends to identify opportunities in commercial properties in the retail, office, and industrial sectors throughout the United States and Canada. The company was formerly known as ACRO Inc. and changed its name to Transatlantic Capital Inc. in May 2014. Transatlantic Capital Inc. was founded in 2002 and is based in Bingham Farms, Michigan. Transatlantic Capital Inc. is a subsidiary of NFA Securities 3LC.

Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.